
ResMed (RMD) Stock Forecast & Price Target
ResMed (RMD) Analyst Ratings
Bulls say
ResMed is reporting strong financial performance for FY26, with a positive revenue outlook driven by increasing prevalence of sleep apnea and ResMed's focus on digital health. However, some concerns remain regarding the competitiveness of European/ROW markets and the company's opex despite high revenue growth. Overall, despite a potentially competitive market and ongoing investments, ResMed's strong performance and focus on innovation make it a promising stock for the future.
Bears say
ResMed is showing strong top-line growth and solid improvements in gross margin and operating margin, indicating good operational performance. However, we are maintaining a neutral outlook due to potential headwinds from competition, regulatory changes, and the impact of the COVID-19 pandemic on the healthcare industry. Additionally, the company's ambitious investment in digital health may result in increased expenses and risks.
This aggregate rating is based on analysts' research of ResMed and is not a guaranteed prediction by Public.com or investment advice.
ResMed (RMD) Analyst Forecast & Price Prediction
Start investing in ResMed (RMD)
Order type
Buy in
Order amount
Est. shares
0 shares